By doing this, and by separating tumor samples by their origin (primary vs metastatic tumor) and MAP17 expression (low vs high), we found a clear trend in this list; appearing small differences according the data set considered. This evidence concerns the gene PDZK1IP1 and metastatic neoplasm.